Nonproliferating bystander CD4+ T cells lacking activation markers support HIV replication during immune activation

被引:22
|
作者
Scales, D
Ni, HP
Shaheen, F
Capodici, J
Cannon, G
Weissman, D
机构
[1] Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr AIDS Res, Philadelphia, PA 19104 USA
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 166卷 / 10期
关键词
D O I
10.4049/jimmunol.166.10.6437
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV replicates primarily in lymphoid tissue and immune activation is a major stimulus in vivo. To determine the cells responsible for HIV replication during Ag-driven T cell activation, we used a novel in vitro model employing dendritic cell presentation of superantigen to CD4(+) T cells. Dendritic cells and CD4(+) T cells are the major constituents of the paracortical region of lymphoid organs, the train site of Ag-specific activation and HIV replication. Unexpectedly, replication occurred in nonproliferating bystander CD4(+) T cells that lacked activation markers. In contrast, activated Ag-specific cells were relatively protected from infection, which was associated with CCR5 and CXC chemokine receptor 4 down-regulation. The finding that HIV replication is not restricted to highly activated Ag-specific CD4(+) T cells has implications for therapy, efforts to eradicate viral reservoirs, immune control of HIV, and Ag-specific immune defects.
引用
收藏
页码:6437 / 6443
页数:7
相关论文
共 50 条
  • [21] Innate immune activation and CD4+ T cell priming during respiratory fungal infection
    Rivera, Amariliz
    Ro, Grace
    Van Epps, Heather L.
    Simpson, Tyler
    Leiner, Ingrid
    Sant'Angelo, Derek B.
    Pamer, Eric G.
    [J]. IMMUNITY, 2006, 25 (04) : 665 - 675
  • [22] CD4+ T cells during priming help naive CD8+ T cell activation
    Chen, Shu-Ching
    Liao, Chi-Chia
    Lai, Yo-Ping
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182
  • [23] HIV Nef is Secreted in Exosomes and Triggers Apoptosis in Bystander CD4+ T Cells
    Lenassi, Metka
    Cagney, Gerard
    Liao, Maofu
    Vaupotic, Tomaz
    Bartholomeeusen, Koen
    Cheng, Yifan
    Krogan, Nevan J.
    Plemenitas, Ana
    Peterlin, B. Matija
    [J]. TRAFFIC, 2010, 11 (01) : 110 - 122
  • [24] Loss of CD127 expression links immune activation and CD4+ T cell loss in HIV infection
    Kiazyk, Sandra A. Koesters
    Fowke, Keith R.
    [J]. TRENDS IN MICROBIOLOGY, 2008, 16 (12) : 567 - 573
  • [25] Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy:: Association of immune activation, T cell maturation markers, and cellular HIV-1 DNA
    Goicoechea, Miguel
    Smith, Davey M.
    Liu, Lin
    May, Susanne
    Tenorio, Allan R.
    Ignacio, Caroline C.
    Landay, Alan
    Haubrich, Richard
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (01): : 29 - 37
  • [26] Cytomegalovirus Replication in Semen Is Associated with Higher Levels of Proviral HIV DNA and CD4+ T Cell Activation during Antiretroviral Treatment
    Gianella, Sara
    Massanella, Marta
    Richman, Douglas D.
    Little, Susan J.
    Spina, Celsa A.
    Vargas, Milenka V.
    Lada, Steven M.
    Daar, Eric S.
    Dube, Michael P.
    Haubrich, Richard H.
    Morris, Sheldon R.
    Smith, Davey M.
    [J]. JOURNAL OF VIROLOGY, 2014, 88 (14) : 7818 - 7827
  • [27] ENTRY OF HIV INTO CD4+ CELLS REQUIRES A T-CELL ACTIVATION ANTIGEN CD26
    KRUST, B
    CALLEBAUT, C
    JACOTOT, E
    HOVANESSIAN, AG
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 144 - 144
  • [28] CD32 Ligation Promotes the Activation of CD4+ T Cells
    Pia Holgado, Maria
    Sananez, Ines
    Raiden, Silvina
    Geffner, Jorge R.
    Arruvito, Lourdes
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [29] ENTRY OF HIV INTO CD4+ CELLS REQUIRES A T-CELL ACTIVATION ANTIGEN CD26
    CALLEBAUT, C
    KRUST, B
    JACOTOT, E
    HOVANESSIAN, AG
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 443 - 443
  • [30] T-CELL ACTIVATION ANTIGEN, CD26, AS A COFACTOR FOR ENTRY OF HIV IN CD4+ CELLS
    CALLEBAUT, C
    KRUST, B
    JACOTOT, E
    HOVANESSIAN, AG
    [J]. SCIENCE, 1993, 262 (5142) : 2045 - 2050